Patients diagnosed with either Huntington’s disease, spasticity or severe muscle spasms, or a terminal illness are now eligible to receive authorizations to access medical cannabis.
The measure makes numerous changes to the state’s medical program — several of which may hamper patients’ access to medical cannabis products.
The measure now heads to the desk of Democratic Governor John Bel Edwards.
The measure expands the list of qualifying medical conditions, which previously only included those with intractable epilepsy.
“This bill is a cynical effort by prohibitionists to severely roll back a policy that has been in place for two decades and that a majority of state residents support.”
Under the new law, patients with insomnia and/or autism spectrum disorder are eligible to obtain medical cannabis access.
The new law will take effect once regulations are established, in which regulators have until March 1, 2022.
The DEA’s website did not provide a timeline as to when it anticipates finalizing the applicants’ grow authorizations or when it plans to take actions on the dozens of remaining applications that are still pending before the agency.